The drug showed promise in early studies but never ever made it to current market. The drug was related to manufacturing a higher degree of “psychological unpleasantness” than other, extra prevalent benzodiazepines like diazepam or lorazepam.  There’s some proof that the α5 BZD receptor is principally associated with the amnesic effe